title: [A comparative study of apoptosis and proliferation of nasal T cell lymphoma].
abstract: A quantitative evaluation and statistical analysis of apoptosis and proliferation in 30 cases of MMR was carried out by means of in situ end-labelling (ISEL) of fragmented DNA technic and expression of Ki-67 antigen in routine paraffin sections with comparison of clinicopathology and prognosis. 28 patients had been followed for 6 to 29 months (mean 12.4 months) and 8 (28.5%) died of relapse and idsease progression. The results showed that (1) the number of apoptotic cells was found to correlate with the ratio of Ki-67 positive cells (P < 0.0063). No significant association of mitotic figures, Ki-67 labelled cells and the expression of bel-2 oncoprotein was observed. The results also did not suggest a correlation of proliferation or apoptosis with the stage of the disease at presentation. (2) statistical analysis revealed a significant impact of Ki-67 positive cells (P < 0.0160) on mean survival time and no significant association among apoptosis, morphologic changes and the mean survival time was found in this group of cases. The relation between apoptosis, proliferation, expression of bcl-2 oncoprotein and EBV infection in related lymphomas were discussed.
authors.affiliation: Department of Pathology, West China University of Medical Sciences, Chengdu.
authors.forename: W
authors.initials: W
authors.lastname: Liu
authors.forename: J
authors.initials: J
authors.lastname: Lorenzen
authors.forename: M L
authors.initials: ML
authors.lastname: Hansmann
mesh_terms: D000328:Adult; D017209:Apoptosis; D002455:Cell Division; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000378:metabolism; D016399:Lymphoma, T-Cell / Q000276:immunology / Q000473:pathology*; D008297:Male; D009669:Nose Neoplasms / Q000276:immunology / Q000473:pathology*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis
chemical_list: D019394:Ki-67 Antigen; D019253:Proto-Oncogene Proteins c-bcl-2